405 related articles for article (PubMed ID: 25809014)
1. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
Davalos RV; Bhonsle S; Neal RE
Prostate; 2015 Jul; 75(10):1114-8. PubMed ID: 25809014
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
Dunki-Jacobs EM; Philips P; Martin RC
Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
[TBL] [Abstract][Full Text] [Related]
3. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study to delineate irreversible electroporation from thermal damage using the arrhenius equation.
Shafiee H; Garcia PA; Davalos RV
J Biomech Eng; 2009 Jul; 131(7):074509. PubMed ID: 19640145
[TBL] [Abstract][Full Text] [Related]
5. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.
Arena CB; Sano MB; Rossmeisl JH; Caldwell JL; Garcia PA; Rylander MN; Davalos RV
Biomed Eng Online; 2011 Nov; 10():102. PubMed ID: 22104372
[TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Characterization of Parameters Affecting High-Frequency Irreversible Electroporation Lesions.
Miklovic T; Latouche EL; DeWitt MR; Davalos RV; Sano MB
Ann Biomed Eng; 2017 Nov; 45(11):2524-2534. PubMed ID: 28721494
[TBL] [Abstract][Full Text] [Related]
7. Development of a thermal model for irreversible electroporation: an approach to estimate and optimize the IRE protocols.
Wardhana G; Almeida JP; Abayazid M; Fütterer JJ
Int J Comput Assist Radiol Surg; 2021 Aug; 16(8):1325-1334. PubMed ID: 34032965
[TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation: just another form of thermal therapy?
van Gemert MJ; Wagstaff PG; de Bruin DM; van Leeuwen TG; van der Wal AC; Heger M; van der Geld CW
Prostate; 2015 Feb; 75(3):332-5. PubMed ID: 25327875
[TBL] [Abstract][Full Text] [Related]
9. A parametric study delineating irreversible electroporation from thermal damage based on a minimally invasive intracranial procedure.
Garcia PA; Rossmeisl JH; Neal RE; Ellis TL; Davalos RV
Biomed Eng Online; 2011 Apr; 10():34. PubMed ID: 21529373
[TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation ablation: is all the damage nonthermal?
Faroja M; Ahmed M; Appelbaum L; Ben-David E; Moussa M; Sosna J; Nissenbaum I; Goldberg SN
Radiology; 2013 Feb; 266(2):462-70. PubMed ID: 23169795
[TBL] [Abstract][Full Text] [Related]
11. Intravascular irreversible electroporation: theoretical and experimental feasibility study.
Maor E; Ivorra A; Rubinsky B
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():2051-4. PubMed ID: 19163098
[TBL] [Abstract][Full Text] [Related]
12. A statistical model for multidimensional irreversible electroporation cell death in tissue.
Golberg A; Rubinsky B
Biomed Eng Online; 2010 Feb; 9():13. PubMed ID: 20187951
[TBL] [Abstract][Full Text] [Related]
13. The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems.
Neal RE; Davalos RV
Ann Biomed Eng; 2009 Dec; 37(12):2615-25. PubMed ID: 19757056
[TBL] [Abstract][Full Text] [Related]
14. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage.
Neal RE; Smith RL; Kavnoudias H; Rosenfeldt F; Ou R; Mclean CA; Davalos RV; Thomson KR
Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1638-1645. PubMed ID: 23942593
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of contribution of mild and moderate hyperthermia to thermal ablation and sensitization of irreversible electroporation of pancreatic cancer cells.
Agnass P; Rodermond HM; van Veldhuisen E; Vogel JA; Ten Cate R; van Lienden KP; van Gulik TM; Franken NAP; Oei AL; Kok HP; Besselink MG; Crezee J
J Therm Biol; 2023 Jul; 115():103619. PubMed ID: 37437370
[TBL] [Abstract][Full Text] [Related]
16. Mathematical modeling of the thermal effects of irreversible electroporation for
Agnass P; van Veldhuisen E; van Gemert MJC; van der Geld CWM; van Lienden KP; van Gulik TM; Meijerink MR; Besselink MG; Kok HP; Crezee J
Int J Hyperthermia; 2020; 37(1):486-505. PubMed ID: 32423258
[No Abstract] [Full Text] [Related]
17. Irreversible electroporation of the porcine kidney: Temperature development and distribution.
Wagstaff PG; de Bruin DM; van den Bos W; Ingels A; van Gemert MJ; Zondervan PJ; Verdaasdonk RM; van Lienden KP; van Leeuwen TG; de la Rosette JJ; Laguna Pes MP
Urol Oncol; 2015 Apr; 33(4):168.e1-7. PubMed ID: 25557146
[TBL] [Abstract][Full Text] [Related]
18. Irreversible electroporation: a new ablation modality--clinical implications.
Rubinsky B; Onik G; Mikus P
Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
[TBL] [Abstract][Full Text] [Related]
19. Cancer cells ablation with irreversible electroporation.
Miller L; Leor J; Rubinsky B
Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
[TBL] [Abstract][Full Text] [Related]
20. Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers.
Jarm T; Krmac T; Magjarevic R; Kos B; Cindric H; Miklavcic D
Biomed Eng Online; 2020 Nov; 19(1):85. PubMed ID: 33198769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
